Literature DB >> 28886000

Inflammatory illness: Why the next wave of antidepressants may target the immune system.

Nicole Wetsman.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28886000     DOI： 10.1038/nm0917-1009

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  12 in total

1.  Association of high-sensitivity C-reactive protein with de novo major depression.

Authors:  Julie A Pasco; Geoffrey C Nicholson; Lana J Williams; Felice N Jacka; Margaret J Henry; Mark A Kotowicz; Hans G Schneider; Brian E Leonard; Michael Berk
Journal:  Br J Psychiatry       Date:  2010-11       Impact factor: 9.319

2.  The history of malariotherapy for neurosyphilis. Modern parallels.

Authors:  S C Austin; P D Stolley; T Lasky
Journal:  JAMA       Date:  1992 Jul 22-29       Impact factor: 56.272

3.  The proinflammatory cytokines interleukin-1beta and tumor necrosis factor-alpha activate serotonin transporters.

Authors:  Chong-Bin Zhu; Randy D Blakely; William A Hewlett
Journal:  Neuropsychopharmacology       Date:  2006-02-01       Impact factor: 7.853

4.  A meta-analysis of cytokines in major depression.

Authors:  Yekta Dowlati; Nathan Herrmann; Walter Swardfager; Helena Liu; Lauren Sham; Elyse K Reim; Krista L Lanctôt
Journal:  Biol Psychiatry       Date:  2009-12-16       Impact factor: 13.382

5.  Endogenous interleukin-10 is required for the defervescence of fever evoked by local lipopolysaccharide-induced and Staphylococcus aureus-induced inflammation in rats.

Authors:  T Cartmell; C Ball; A F Bristow; D Mitchell; S Poole
Journal:  J Physiol       Date:  2003-04-11       Impact factor: 5.182

6.  A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers.

Authors:  Charles L Raison; Robin E Rutherford; Bobbi J Woolwine; Chen Shuo; Pamela Schettler; Daniel F Drake; Ebrahim Haroon; Andrew H Miller
Journal:  JAMA Psychiatry       Date:  2013-01       Impact factor: 21.596

7.  Tumor necrosis factor and its targets in the inflammatory cytokine pathway are identified as putative transcriptomic biomarkers for escitalopram response.

Authors:  Timothy R Powell; Leonard C Schalkwyk; Andrew L Heffernan; Gerome Breen; Timothy Lawrence; Tom Price; Anne E Farmer; Katherine J Aitchison; Ian W Craig; Andrea Danese; Cathryn Lewis; Peter McGuffin; Rudolf Uher; Katherine E Tansey; Ursula M D'Souza
Journal:  Eur Neuropsychopharmacol       Date:  2012-11-09       Impact factor: 4.600

8.  Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study.

Authors:  Golam M Khandaker; Rebecca M Pearson; Stanley Zammit; Glyn Lewis; Peter B Jones
Journal:  JAMA Psychiatry       Date:  2014-10       Impact factor: 21.596

9.  Replicable and Coupled Changes in Innate and Adaptive Immune Gene Expression in Two Case-Control Studies of Blood Microarrays in Major Depressive Disorder.

Authors:  Gwenaël G R Leday; Petra E Vértes; Sylvia Richardson; Jonathan R Greene; Tim Regan; Shahid Khan; Robbie Henderson; Tom C Freeman; Carmine M Pariante; Neil A Harrison; V Hugh Perry; Wayne C Drevets; Gayle M Wittenberg; Edward T Bullmore
Journal:  Biol Psychiatry       Date:  2017-07-06       Impact factor: 13.382

10.  Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients.

Authors:  Annamaria Cattaneo; Clarissa Ferrari; Rudolf Uher; Luisella Bocchio-Chiavetto; Marco Andrea Riva; Carmine M Pariante
Journal:  Int J Neuropsychopharmacol       Date:  2016-09-30       Impact factor: 5.176
View more
  2 in total

Review 1.  Recent Advances in CNS P2X7 Physiology and Pharmacology: Focus on Neuropsychiatric Disorders.

Authors:  Anindya Bhattacharya
Journal:  Front Pharmacol       Date:  2018-02-01       Impact factor: 5.810

Review 2.  The Two-Faced Cytokine IL-6 in Host Defense and Diseases.

Authors:  Masashi Narazaki; Tadamitsu Kishimoto
Journal:  Int J Mol Sci       Date:  2018-11-09       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.